The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility study of neoadjuvant chemoradiotherapy with cisplatin plus 5-fluorouracil and elective nodal irradiation for stage II/III esophageal squamous cell carcinoma.
Takashi Kojima
No relevant relationships to disclose
Jun Hashimoto
No relevant relationships to disclose
Ken Kato
No relevant relationships to disclose
Yoshinori Ito
No relevant relationships to disclose
Hiroyasu Igaki
No relevant relationships to disclose
Hiroyuki Daiko
No relevant relationships to disclose
Masakatsu Onozawa
No relevant relationships to disclose
Yasuo Hamamoto
No relevant relationships to disclose
Hideaki Shimizu
No relevant relationships to disclose
Susumu Katano
No relevant relationships to disclose
Hiroki Hara
No relevant relationships to disclose
Yoichi Tanaka
No relevant relationships to disclose
Yoshihiro Saito
No relevant relationships to disclose